SALT LAKE CITY - LifeVantage Corporation (NASDAQ:LFVN), a $271 million market cap player in the health and wellness sector with impressive 79% gross profit margins, today announced the successful ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
LifeVantage (LFVN) announced the completion of an international in vitro cell study that investigated the effects of its international ...
A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
Dr Karan Rangarajan said that some foods may increase your sense of satiety, but warned that no item is a magic solution ...
The international formula was designed to deliver all the benefits of the US formula while meeting regulatory requirements ...
A doctor emphasized that ozempic, a lab-engineered drug, effectively activates GLP-1 receptors for weight loss, unlike foods ...
When Trova Wine and Market shut its doors last month after nearly five years in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like Ozempic.
Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...
Working with a weight management program can help sustain the use of GLP-1 therapies and address potential side effects. Patient education and expectation management are crucial for maximizing ...
Can GLP-1 Meds Harm Your Eyes? By Ernie Mundell HealthDay Reporter MONDAY, Feb. 10, 2025 (HealthDay News) -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss ...
To assess the impact of GLP-1 agonists on incidence and management of adhesive capsulitis, Bergstein and colleagues used the PearlDiver database to perform a retrospective cohort comparison of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback